Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - CIHR/Rx&D - Wyeth Pharmaceuticals Research Program

Université Laval

$45,000.00

Genomic approaches to antibiotic resistance Streptococcus pneumoniae

FY 2008-09

Summary
The discovery of antimicrobial agents was one of the great triumphs of the 20th century. In less than 50 years, however, we have moved from the age of antibiotics to the age of antibiotic resistance. The emergence of resistance has numerous social and economic implications Canada is not exceptional. In the last 5 years, Canada has experienced a rapid increase in penicillin and multidrug resistant S. pneumoniae. The current study will corroborate the functional genomic approach including comparative genome sequencing and global expression profiling of proteins and genes from drug susceptible and resistant S. pneumoniae. The resistant strains of S. pneumoniae to three antibiotics were selected on the basis standard methods. Comparative genome sequencing (CGS) of two independent mutants for each antibiotic and PCR sequencing the distributions of mutations in different cells, and expression profiling experiments (with RNA and proteins) of sensitive and resistant isolates will studies. Further, biological validation of selected mutations will also study. This work should highlight how microorganisms alter their gene expression to learn to live with a resistant genotype. We shall be able to pinpoint adaptive mutations and compensatory mechanisms that contribute to the fitness of resistant microorganisms and reveal new principles towards pharmaceutical agents. The proposed studies should facilitate the discovery of novel primary resistance mechanisms and will provide, for the first time, a roadmap of the compensatory and adaptive fitness mutations arising upon the emergence of resistance. Using the above techniques novel markers of resistance have been found and this led either to the ongoing development of diagnostic assays or to the suggestion of novel drug combination.
Program
Fellowship - CIHR/Rx&D - Wyeth Pharmaceuticals Research Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
182333
Name
Billal Dewan S
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Wyeth Pharmaceuticals
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Industry Partnered Collaborative Research
Projecttitle
Genomic approaches to antibiotic resistance Streptococcus pneumoniae
Programtype2
Fellowship Programs
Orgnameinp2
Université Laval
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - CIHR/Rx&D - Wyeth Pharmaceuticals Research Program
Keyworddelim
Genomic; Mutation; Proteomics; Resistance; Streptococcus Pneumoniae; Susceptible
Abstract
The discovery of antimicrobial agents was one of the great triumphs of the 20th century. In less than 50 years, however, we have moved from the age of antibiotics to the age of antibiotic resistance. The emergence of resistance has numerous social and economic implications Canada is not exceptional. In the last 5 years, Canada has experienced a rapid increase in penicillin and multidrug resistant S. pneumoniae. The current study will corroborate the functional genomic approach including comparative genome sequencing and global expression profiling of proteins and genes from drug susceptible and resistant S. pneumoniae. The resistant strains of S. pneumoniae to three antibiotics were selected on the basis standard methods. Comparative genome sequencing (CGS) of two independent mutants for each antibiotic and PCR sequencing the distributions of mutations in different cells, and expression profiling experiments (with RNA and proteins) of sensitive and resistant isolates will studies. Further, biological validation of selected mutations will also study. This work should highlight how microorganisms alter their gene expression to learn to live with a resistant genotype. We shall be able to pinpoint adaptive mutations and compensatory mechanisms that contribute to the fitness of resistant microorganisms and reveal new principles towards pharmaceutical agents. The proposed studies should facilitate the discovery of novel primary resistance mechanisms and will provide, for the first time, a roadmap of the compensatory and adaptive fitness mutations arising upon the emergence of resistance. Using the above techniques novel markers of resistance have been found and this led either to the ongoing development of diagnostic assays or to the suggestion of novel drug combination.
Competitiondate
200902
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Billal, Dewan S
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $45,000~ $0~